Investment Rating - The report assigns an "Overweight" rating for the industry [3][14] - The specific sub-industry ratings are also "Overweight" for both pharmaceutical manufacturing and pharmaceutical services [3][14] Core Insights - The overall income of the medical insurance fund for January to October 2025 is reported at 23,520.10 billion yuan, reflecting a year-on-year growth of 2.0%. However, the income from urban and rural residents' insurance has slightly decreased by 4.3% [3][4] - The total expenditure of the medical insurance fund during the same period is 19,036.24 billion yuan, showing a decline of 0.7% year-on-year. The expenditure for urban employees increased by 2.2%, while that for rural residents decreased by 4.4% [3][4] - The cumulative surplus of the medical insurance fund as of October 2025 is 4,483.86 billion yuan, with a surplus rate of 19.1%. The urban employee fund has a surplus rate of 27.8%, while the rural residents' fund has a lower rate of 3.3% [3][4] Summary by Sections Medical Insurance Fund Income and Expenditure - Cumulative income from January to October 2025: 23,520.10 billion yuan (+2.0% YoY) - Cumulative expenditure during the same period: 19,036.24 billion yuan (-0.7% YoY) - October 2025 income: 2,434.40 billion yuan (-16.0% YoY) - October 2025 expenditure: 1,756.64 billion yuan (+10.7% YoY) [3][4][9] Surplus and Fiscal Expenditure - Cumulative surplus for January to October 2025: 4,483.86 billion yuan (surplus rate 19.1%) - Cumulative health expenditure from the general public budget: 16,877 billion yuan (+2.4% YoY) [3][7]
医保基金运行月报:医保收入增长平稳,支出同比放缓-20251216
GUOTAI HAITONG SECURITIES·2025-12-16 11:13